Accounting for more than 40% of all heart failure problems, diastolic heart failure is a complex and often difficult diagnosis with rapidly evolving diagnostic management protocols. Diastology: Clinical Approach to Heart Failure with Preserved Ejection Fraction, 2nd Edition, brings you up to date and equips you to successfully diagnose and manage even the most challenging incidences of diastolic heart failure and their comorbidities. It incorporates the latest guidelines for the diagnostic evaluation of the patient with suspected or known diastolic dysfunction, provides a comprehensive review of clinical conditions associated with heart failure with preserved ejection fraction, and describes the complementary role of imaging modalities and novel therapeutic approaches.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. IFC - p. iii 5. Copyright - p. IFC1 6. List of Contributors - p. iv 7. Foreword - p. viii 8. Foreword - p. ix 9. Preface - p. x 10. Acknowledgments - p. xi 11. Video Table of Contents - p. xii 12. List of Illustrations - p. xvi 13. List of Tables - p. xvi 14. Part I: Basic Determinants of Diastolic Function - p. xvi 15. Chapter 1: Molecular, Gene, and Cellular Mechanism - p. xvi 16. Chapter 2: Pathophysiology of Heart Failure With a Preserved Ejection Fraction: Measurements and Mechanisms Causing Abnormal Diastolic Function - p. 10 17. Chapter 3: Role of the Pericardium in Diastolic Dysfunction - p. 30 18. Chapter 4: Left Atrial Function: Basic Physiology - p. 39 19. Chapter 5: Physical Determinants of Diastolic Flow - p. 52 20. Chapter 6: Ventricular–Arterial Interaction in Patients With Heart Failure and a Preserved Ejection Fraction - p. 70 21. Part II: Diagnosis of Heart Failure With Preserved Ejection Fraction - p. 85 22. Chapter 7: General Principles, Clinical Definition, Epidemiology, and Pathophysiology - p. 85 23. Chapter 8: Invasive Hemodynamic Assessment in Heart Failure With Preserved Ejection Fraction - p. 92 24. Chapter 9: Two-Dimensional and Doppler Evaluation of Left Ventricular Filling, Including Pulmonary Venous Flow Velocity - p. 105 25. Chapter 10: Evaluation of Diastolic Function by Tissue Doppler, Strain, and Torsion Analysis - p. 136 26. Chapter 11: Color M-mode Doppler - p. 149 27. Chapter 12: Assessment of Left Atrial Size and Function - p. 156 28. Chapter 13: Evaluation of Intracardiac Filling Pressures - p. 168 29. Chapter 14: Evaluation of Right Ventricular Diastolic Function - p. 179 30. Chapter 15: Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging - p. 190 31. Chapter 16: Evaluation of Diastolic Function by Radionuclide Techniques - p. 205 32. Chapter 17: Diastolic Echocardiographic Examination - p. 216 33. Chapter 18: Diastology Stress Test - p. 239 34. Chapter 19: ASE/EACVI Diastolic Guidelines: Strength and Limitations - p. 248 35. Part III: Cardiac Diseases With HFpEF - p. 257 36. Chapter 20: Hypertension and Its Relation to Heart Failure With a Preserved Ejection Fraction - p. 257 37. Chapter 21: Valve Disease - p. 267 38. Chapter 22: Stage D Heart Failure With Preserved Ejection Fraction, Heart Transplantation, and Mechanical Circulatory Support - p. 275 39. Chapter 23: Primary Restrictive, Infiltrative, and Storage Cardiomyopathies - p. 289 40. Chapter 24: Coronary Artery Disease - p. 307 41. Chapter 25: Hypertrophic Cardiomyopathy - p. 321 42. Chapter 26: Pericardial Diseases: Constrictive Pericarditis and Pericardial Effusion - p. 333 43. Chapter 27: Diastolic Function in Children and in Children With Congenital Heart Disease - p. 348 44. Chapter 28: Diabetes Mellitus - p. 374 45. Part IV: Emerging Topics in HFpEF - p. 390 46. Chapter 29: Global and Regional Systolic Function of the Left Ventricle - p. 390 47. Chapter 30: Chronotropic Incompetence and Pacing in HPEF Heart Failure with Preserved Ejection Fraction - p. 413 48. Chapter 31: Aging and Heart Failure With Preserved Ejection Fraction - p. 424 49. Chapter 32: Perioperative Assessment of Diastolic Function - p. 441 50. Chapter 33: Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction - p. 451 51. Part V: Treatment of HFpEF - p. 462 52. Chapter 34: General Treatment of Heart Failure With Preserved Ejection Fraction and Randomized Trials - p. 462 53. Chapter 35: Echo-Based Approach to the Management of Heart Failure With Preserved Ejection Fraction - p. 472 54. Chapter 36: Future Therapies in HFpEF - p. 488 55. Part VI: Cases of Diastolic Heart Failure - p. 494 56. Chapter 37: Cases of Diastolic Heart Failure - p. 494 57. Review Question Answers - p. e.22 58. Index - p. 509 59. IBC - p. 523
Accounting for more than 40% of all heart failure problems, diastolic heart failure is a complex and often difficult diagnosis with rapidly evolving diagnostic management protocols. Diastology: Clinical Approach to Heart Failure with Preserved Ejection Fraction, 2nd Edition, brings you up to date and equips you to successfully diagnose and manage even the most challenging incidences of diastolic heart failure and their comorbidities. It incorporates the latest guidelines for the diagnostic evaluation of the patient with suspected or known diastolic dysfunction, provides a comprehensive review of clinical conditions associated with heart failure with preserved ejection fraction, and describes the complementary role of imaging modalities and novel therapeutic approaches.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. IFC - p. iii 5. Copyright - p. IFC1 6. List of Contributors - p. iv 7. Foreword - p. viii 8. Foreword - p. ix 9. Preface - p. x 10. Acknowledgments - p. xi 11. Video Table of Contents - p. xii 12. List of Illustrations - p. xvi 13. List of Tables - p. xvi 14. Part I: Basic Determinants of Diastolic Function - p. xvi 15. Chapter 1: Molecular, Gene, and Cellular Mechanism - p. xvi 16. Chapter 2: Pathophysiology of Heart Failure With a Preserved Ejection Fraction: Measurements and Mechanisms Causing Abnormal Diastolic Function - p. 10 17. Chapter 3: Role of the Pericardium in Diastolic Dysfunction - p. 30 18. Chapter 4: Left Atrial Function: Basic Physiology - p. 39 19. Chapter 5: Physical Determinants of Diastolic Flow - p. 52 20. Chapter 6: Ventricular–Arterial Interaction in Patients With Heart Failure and a Preserved Ejection Fraction - p. 70 21. Part II: Diagnosis of Heart Failure With Preserved Ejection Fraction - p. 85 22. Chapter 7: General Principles, Clinical Definition, Epidemiology, and Pathophysiology - p. 85 23. Chapter 8: Invasive Hemodynamic Assessment in Heart Failure With Preserved Ejection Fraction - p. 92 24. Chapter 9: Two-Dimensional and Doppler Evaluation of Left Ventricular Filling, Including Pulmonary Venous Flow Velocity - p. 105 25. Chapter 10: Evaluation of Diastolic Function by Tissue Doppler, Strain, and Torsion Analysis - p. 136 26. Chapter 11: Color M-mode Doppler - p. 149 27. Chapter 12: Assessment of Left Atrial Size and Function - p. 156 28. Chapter 13: Evaluation of Intracardiac Filling Pressures - p. 168 29. Chapter 14: Evaluation of Right Ventricular Diastolic Function - p. 179 30. Chapter 15: Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging - p. 190 31. Chapter 16: Evaluation of Diastolic Function by Radionuclide Techniques - p. 205 32. Chapter 17: Diastolic Echocardiographic Examination - p. 216 33. Chapter 18: Diastology Stress Test - p. 239 34. Chapter 19: ASE/EACVI Diastolic Guidelines: Strength and Limitations - p. 248 35. Part III: Cardiac Diseases With HFpEF - p. 257 36. Chapter 20: Hypertension and Its Relation to Heart Failure With a Preserved Ejection Fraction - p. 257 37. Chapter 21: Valve Disease - p. 267 38. Chapter 22: Stage D Heart Failure With Preserved Ejection Fraction, Heart Transplantation, and Mechanical Circulatory Support - p. 275 39. Chapter 23: Primary Restrictive, Infiltrative, and Storage Cardiomyopathies - p. 289 40. Chapter 24: Coronary Artery Disease - p. 307 41. Chapter 25: Hypertrophic Cardiomyopathy - p. 321 42. Chapter 26: Pericardial Diseases: Constrictive Pericarditis and Pericardial Effusion - p. 333 43. Chapter 27: Diastolic Function in Children and in Children With Congenital Heart Disease - p. 348 44. Chapter 28: Diabetes Mellitus - p. 374 45. Part IV: Emerging Topics in HFpEF - p. 390 46. Chapter 29: Global and Regional Systolic Function of the Left Ventricle - p. 390 47. Chapter 30: Chronotropic Incompetence and Pacing in HPEF Heart Failure with Preserved Ejection Fraction - p. 413 48. Chapter 31: Aging and Heart Failure With Preserved Ejection Fraction - p. 424 49. Chapter 32: Perioperative Assessment of Diastolic Function - p. 441 50. Chapter 33: Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction - p. 451 51. Part V: Treatment of HFpEF - p. 462 52. Chapter 34: General Treatment of Heart Failure With Preserved Ejection Fraction and Randomized Trials - p. 462 53. Chapter 35: Echo-Based Approach to the Management of Heart Failure With Preserved Ejection Fraction - p. 472 54. Chapter 36: Future Therapies in HFpEF - p. 488 55. Part VI: Cases of Diastolic Heart Failure - p. 494 56. Chapter 37: Cases of Diastolic Heart Failure - p. 494 57. Review Question Answers - p. e.22 58. Index - p. 509 59. IBC - p. 523
